EPRX
ANALYST COVERAGE2 analysts
BUY
+173.8%upside to target
Buy
2100%
2 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
PRICE
Prev Close
6.37
Open
6.44
Day Range6.44 – 7.26
6.44
7.26
52W Range3.67 – 9.32
3.67
9.32
58% of range
VOLUME & SIZE
Avg Volume
199.3K
FUNDAMENTALS
P/E Ratio
-6.6x
Not profitable
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
38
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 96 days
Aug 26

EPRX News

About

No description available.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Mark KowalskiChief Medical Officer
Alexander John RothwellChief Financial Officer
Alex TherienExecutive VP of R&D
Paul Anthony BrennanChief Corporate Development Officer
Jeymi TambiahChief Medical Officer
James A. Helliwell FRCPCChief Executive Officer & Director
Amanda MaloneChief Scientific Officer & Chief Operating Officer